Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 4Neoplasms 2Prostatic Diseases 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Prostate-Specific Antigen × Clear all
NCT00853710 2025-11-20

Test Semiquantitative Prostate Specific Antigen (PSA)

Institut Curie

Phase NA Completed
94 enrolled
Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms

NCT02419846 2022-07-25

Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program

Case Comprehensive Cancer Center

Phase NA Terminated
319 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT04063566 2021-10-15

ReIMAGINE Prostate Cancer Screening

University College, London

Phase NA Completed
309 enrolled
Genitourinary

Prostatic Neoplasms

NCT02710422 2019-09-11

MMEP

University of Miami

Phase 2 Terminated
24 enrolled 14 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡